Tenaya Therapeutics, Inc.

NASDAQ:TNYA

0.6702 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -111.129-124.084-123.665-72.721-38.395-26.231
Depreciation & Amortization 8.2848.6876.4672.9612.4831.989
Deferred Income Tax 0000.1920.033-0.082
Stock Based Compensation 16.50115.30911.4672.950.7410.414
Change In Working Capital -7.931-5.648-0.8494.742-0.234-0.25
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.581-3.2821.668.60.1420.397
Other Working Capital -7.35-2.366-2.509-3.858-0.376-0.647
Other Non Cash Items 3.7743.6642.1561.064-0.0750.064
Operating Cash Flow -90.501-102.072-104.424-60.812-35.447-24.096
Investing Activities:
Investments In Property Plant And Equipment -1.025-1.239-20.63-25.121-9.763-2.926
Acquisitions Net 000000.003
Purchases Of Investments -87.069-56.644-140.476-213.4430-12.657
Sales Maturities Of Investments 89.208106.623244.7502.75310
Other Investing Activites 0.017-0.0250.008-0.2130.003-0.003
Investing Cash Flow 1.13148.71583.652-238.564-7.01-5.583
Financing Activities:
Debt Repayment 000000
Common Stock Issued 46.7623.86877.387188.54100
Common Stock Repurchased 000-0.013-0.001-0.003
Dividends Paid 000000
Other Financing Activities 0.9870.1810.3820.442147.26930.514
Financing Cash Flow 47.7494.04977.767208.97147.26830.511
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -41.621-49.30856.995-90.406104.8110.832
Cash At End Of Period 4.74246.36395.67138.676129.08224.271